Riesgo de nefrotoxicidad                                                               Risk of nephrotoxicity  

Mrvos R, Pummer TL, Krenzelok EP. Amoxicillin renal toxicity: how often does it occur? Pediatr Emerg Care. 2013; 29(5):641-3. doi: 10.1097/PEC.0b013e31828e9e78.

Karino F, Miura K, Fuchita H, Koba N, Nishikawa E, Hotta T, et al. Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia. J Infect Chemother. 2013; 19(5):909-15. doi: 10.1007/s10156-013-0605-x.

Rank W. Preventing contrast media-induced nephrotoxicity. Nursing. 2013; 43(4):48-51. doi: 10.1097/01.NURSE.0000427100.98269.76.

Hebert MF, Zheng S, Hays K, Shen DD, Davis CL, Umans JG, et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation. 2013; 95(7):908-15. doi:10.1097/TP.0b013e318278d367.

Garbin LM, Tonani M, Salvador M, de Campos Pereira Silveira RC, Voltarelli JC, dos Santos CB, Carvalho EC. Cyclosporine level: difference between blood samples collected through peripheral and central venous access. J Clin Nurs. 2013; 22(3-4):395-404. doi: 10.1111/j.1365-2702.2012.04187.x.

Jensen JU, Hein L, Lundgren B, Bestle MH, Mohr T, Andersen MH, et al. Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial. BMJ Open. 2012 Mar 11;2(2):e000635. doi: 10.1136/bmjopen-2011-000635.

Hicks RW, Hernandez J. Perioperative pharmacology: a focus on vancomycin. AORN J. 2011; 93(5):593-6.

Bruce K, Hicks RW. Perioperative pharmacology: a focus on aminoglycosides. AORN J. 2011; 93(4):464-8.

Ouwerkerk J, Boers-Doets C. Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer. Eur J Oncol Nurs. 2010; 14(4):337-49.

Cooper RG. Effect of tobacco smoking on renal function. Indian J Med Res. 2006; 124(3):261-8.

McMahon DM, Winstead S, Weant KA. Toxic alcohol ingestions: focus on ethylene glycol and methanol. Adv Emerg Nurs J. 2009; 31(3):206-13.

Andreu L, Force E. Nephrotoxicity and Medicines. EDTNA ERCA J. 2004; 30(2):54-7.

Thompson EJ, King SL. Acetylcysteine and fenoldopam. Promising new approaches for preventing effects of contrast nephrotoxicity. Crit Care Nurse. 2003; 23(3):39-46.

Anastasia PJ. Nursing considerations for managing topotecan-related hematologic side effects. Clin J Oncol Nurs. 2001; 5(1):9-13. 

Versión para imprimir Versión para imprimir | Mapa del sitio
© NAAXPOT SLU © ATIC